소 태아 혈청 시장 2025-2029년
소 태아 혈청 시장은 2024-2029년에 3억 6,420만 달러, 예측 기간 중 CAGR은 6.1%로 성장할 것으로 예측됩니다. 소 태아 혈청 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
이 보고서는 현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 줄기세포 애플리케이션의 채택 증가, 만성질환의 유병률 증가, 축산 산업의 성장에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준연도 |
2025년 |
| 종료연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2025년 |
5.4% |
| CAGR |
6.1% |
| 증분액 |
3억 6,420만 달러 |
이 보고서는 세포 기반 제약 연구에서의 용도 확대가 향후 수년간 소 태아 혈청 시장의 성장을 주도할 주요 요인 중 하나및 분석했습니다. 또한 질병 관리에 대한 관심 증가와 예방 의학의 채택 확대도 이 시장의 큰 수요로 이어질 것으로 예상됩니다.
목차
제1장 개요
제2장 Technavio별 분석
- 가격·수명주기·고객 구입 바스켓·채택률·구입 기준의 분석
- 인풋의 중요성과 차별화의 요인
- 혼란의 요인
- 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024
- 시장 전망 2024-2029
제5장 시장 규모 실적
- 세계의 소 태아 혈청 시장 2019-2023
- 용도별 부문 분석 2019-2023
- 최종사용자별 부문 분석 2019-2023
- 지역별 부문 분석 2019-2023
- 국가별 부문 분석 2019-2023
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제8장 시장 세분화 : 용도별
- 시장 부문
- 비교 : 용도별
- 바이오의약품 : 시장 규모와 예측 2024-2029
- 사람·동물 백신 : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 용도별
제9장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 제약·바이오의약품 기업 : 시장 규모와 예측 2024-2029
- 계약 조사기관 : 시장 규모와 예측 2024-2029
- 학술 조사기관 : 시장 규모와 예측 2024-2029
- 시장 기회 : 최종사용자별
제10장 고객 상황
제11장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029
- 유럽 : 시장 규모와 예측 2024-2029
- 아시아 : 시장 규모와 예측 2024-2029
- 세계의 기타 지역 : 시장 규모와 예측 2024-2029
- 미국 : 시장 규모와 예측 2024-2029
- 독일 : 시장 규모와 예측 2024-2029
- 중국 : 시장 규모와 예측 2024-2029
- 영국 : 시장 규모와 예측 2024-2029
- 캐나다 : 시장 규모와 예측 2024-2029
- 프랑스 : 시장 규모와 예측 2024-2029
- 일본 : 시장 규모와 예측 2024-2029
- 인도 : 시장 규모와 예측 2024-2029
- 이탈리아 : 시장 규모와 예측 2024-2029
- 한국 : 시장 규모와 예측 2024-2029
- 시장 기회 : 지역 상황별
제12장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제13장 경쟁 구도
제14장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Animal Technologies Inc.
- Atlas Biologicals Inc.
- Bio Techne Corp.
- Corning Inc.
- Danaher Corp.
- Grifols SA
- HiMedia Laboratories Pvt. Ltd.
- Itoham Yonekyu Holdings Inc.
- Merck KGaA
- PAN Biotech
- Rocky Mountain Biologicals
- Sartorius AG
- TCS Biosciences Ltd.
- Thermo Fisher Scientific Inc.
- Tissue Culture Biologicals
제15장 부록
KSA
Fetal Bovine Serum Market 2025-2029
The fetal bovine serum market is forecasted to grow by USD 364.2 mn during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the fetal bovine serum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of stem cell applications, increasing prevalence of chronic diseases, and livestock industry growth.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 5.4% |
| CAGR | 6.1% |
| Incremental Value | $364.2 mn |
Technavio's fetal bovine serum market is segmented as below:
By Application
- Biopharmaceuticals
- Human and animal vaccine
- Others
By End-user
- Pharmaceutical and biopharmaceutical companies
- Contract research organization
- Academic and research organization
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing application in cell-based pharmaceutical research as one of the prime reasons driving the fetal bovine serum market growth during the next few years. Also, increased focus on disease management and growing adoption of preventive care will lead to sizable demand in the market.
The report on the fetal bovine serum market covers the following areas:
- Fetal Bovine Serum Market sizing
- Fetal Bovine Serum Market forecast
- Fetal Bovine Serum Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fetal bovine serum market vendors that include Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Celtic Molecular Diagnostics, Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Tissue Culture Biologicals. Also, the fetal bovine serum market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Fetal Bovine Serum Market 2019 - 2023
- Historic Market Size - Data Table on Global Fetal Bovine Serum Market 2019 - 2023 ($ million)
- 5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The Impact of AI on global fetal bovine serum market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
- 8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 8.3 Biopharmaceuticals - Market size and forecast 2024-2029
- Chart on Biopharmaceuticals - Market size and forecast 2024-2029 ($ million)
- Data Table on Biopharmaceuticals - Market size and forecast 2024-2029 ($ million)
- Chart on Biopharmaceuticals - Year-over-year growth 2024-2029 (%)
- Data Table on Biopharmaceuticals - Year-over-year growth 2024-2029 (%)
- 8.4 Human and animal vaccine - Market size and forecast 2024-2029
- Chart on Human and animal vaccine - Market size and forecast 2024-2029 ($ million)
- Data Table on Human and animal vaccine - Market size and forecast 2024-2029 ($ million)
- Chart on Human and animal vaccine - Year-over-year growth 2024-2029 (%)
- Data Table on Human and animal vaccine - Year-over-year growth 2024-2029 (%)
- 8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029
- Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
- Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ million)
- Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
- 9.4 Contract research organization - Market size and forecast 2024-2029
- Chart on Contract research organization - Market size and forecast 2024-2029 ($ million)
- Data Table on Contract research organization - Market size and forecast 2024-2029 ($ million)
- Chart on Contract research organization - Year-over-year growth 2024-2029 (%)
- Data Table on Contract research organization - Year-over-year growth 2024-2029 (%)
- 9.5 Academic and research organization - Market size and forecast 2024-2029
- Chart on Academic and research organization - Market size and forecast 2024-2029 ($ million)
- Data Table on Academic and research organization - Market size and forecast 2024-2029 ($ million)
- Chart on Academic and research organization - Year-over-year growth 2024-2029 (%)
- Data Table on Academic and research organization - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.9 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.11 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 11.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.1 Market drivers
- 12.2 Market challenges
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Animal Technologies Inc.
- Animal Technologies Inc. - Overview
- Animal Technologies Inc. - Product / Service
- Animal Technologies Inc. - Key offerings
- SWOT
- 14.5 Atlas Biologicals Inc.
- Atlas Biologicals Inc. - Overview
- Atlas Biologicals Inc. - Product / Service
- Atlas Biologicals Inc. - Key offerings
- SWOT
- 14.6 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
- 14.7 Corning Inc.
- Corning Inc. - Overview
- Corning Inc. - Business segments
- Corning Inc. - Key news
- Corning Inc. - Key offerings
- Corning Inc. - Segment focus
- SWOT
- 14.8 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
- 14.9 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key news
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- SWOT
- 14.10 HiMedia Laboratories Pvt. Ltd.
- HiMedia Laboratories Pvt. Ltd. - Overview
- HiMedia Laboratories Pvt. Ltd. - Product / Service
- HiMedia Laboratories Pvt. Ltd. - Key offerings
- SWOT
- 14.11 Itoham Yonekyu Holdings Inc.
- Itoham Yonekyu Holdings Inc. - Overview
- Itoham Yonekyu Holdings Inc. - Business segments
- Itoham Yonekyu Holdings Inc. - Key offerings
- Itoham Yonekyu Holdings Inc. - Segment focus
- SWOT
- 14.12 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 14.13 PAN Biotech
- PAN Biotech - Overview
- PAN Biotech - Product / Service
- PAN Biotech - Key offerings
- SWOT
- 14.14 Rocky Mountain Biologicals
- Rocky Mountain Biologicals - Overview
- Rocky Mountain Biologicals - Product / Service
- Rocky Mountain Biologicals - Key offerings
- SWOT
- 14.15 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key news
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
- 14.16 TCS Biosciences Ltd.
- TCS Biosciences Ltd. - Overview
- TCS Biosciences Ltd. - Product / Service
- TCS Biosciences Ltd. - Key offerings
- SWOT
- 14.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 14.18 Tissue Culture Biologicals
- Tissue Culture Biologicals - Overview
- Tissue Culture Biologicals - Product / Service
- Tissue Culture Biologicals - Key offerings
- SWOT
15 Appendix
- 15.1 Scope of the report
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
